Reply to Little et al.: Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors

Radiation and Environmental Biophysics

Volumn 52, Issue 1, 2013, Pages 161-163

  Schollnberger H ^a   Kaiser, J C ^a   Walsh, L ^b   Jacob, P ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b BUNDESAMT FÜR STRAHLENSCHUTZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMIC BOMB; BASAL GANGLION HEMORRHAGE; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; MALE; MORTALITY; NOTE; RADIATION INJURY;

BASAL GANGLIA CEREBROVASCULAR DISEASE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; NUCLEAR WEAPONS; RADIATION INJURIES;

EID: 84874381664     PISSN: 0301634X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00411-012-0454-5     Document Type: Letter

References (16)

1. Crainiceanu CM, Dominici F, Parmigiani G (2008) Adjustment uncertainty in effect estimation. Biometrika 95:635-651
2. Dominici F, McDermott A, Hastie TJ (2004) Improved semiparametric time series models of air pollution and mortality. J Am Stat Assoc 99:938-948
3. Gutman R, Rubin DB (2012) Analyses that inform policy decisions. Biometrics 68:671-675
4. Little MP, Bazyka D, Bouffler SD, Harrison JD, Cardis E, Cucinotta FA, Kreuzer M, Laurent O, Tapio S, Wakeford R, Zablotska L, Lipshultz SE (2012) Estimating risk of circulatory disease: Little et al. Respond. Environ Health Perspect 120:A 453-A 454. doi: 10.1289/ehp.1206046R
5. Little MP, Azizova TV, Bazyka D, Bouffler SD, Cardis E, Chekin S, Chumak VV, Cucinotta FA, de Vathaire F, Hall P, Harrison JD, Hildebrandt G, Ivanov V, Kashcheev VV, Klymenko SV, Laurent O, Ozasa K, Tapio S, Taylor AM, Tzoulaki I, Vandoolaeghe WL, Wakeford R, Zablotska L, Zhang W, Lipshultz SE (2013) Comment on "Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors" by Schöllnberger et al. Radiat Environ Biophys, doi: 10.1007/s00411-012-0453-6
6. -/- mice. Radiat Res 175:665-676
7. -/- mice: the influence of p53 heterozygosity. Radiat Res. doi: 10.1667/RR3140.1
8. Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Grant EJ, Sakata R, Sugiyama H, Kodama K (2012) Studies of the mortality of atomic bomb survivors, report 14, 1950-2003: an overview of cancer and non cancer diseases. Radiat Res 177:229-243
9. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K (2003) Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 160:381-407
10. Rödel F, Frey B, Gaipl U, Keilholz L, Fournier C, Manda K, Schöllnberger H, Hildebrandt G, Rödel C (2012) Modulation of inflammatory immune reactions by low-dose ionizing radiation: molecular mechanisms and clinical application. Curr Med Chem 19:1741-1750
11. Schöllnberger and Kaiser (2012) Estimating risk of circulatory disease from exposure to low-level ionizing radiation. Environ Health Perspect 120:A 452-A 453. doi: 10.1289/ehp.1206046
12. Schöllnberger H, Kaiser JC, Jacob P, Walsh L (2012) Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors. Radiat Environ Biophys 51:165-178
13. Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, Grant EJ, Sugiyama H, Sakata R, Moriwaki H, Hayashi M, Konda M, Shore RE (2010) Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ 340:b5349
14. Takahashi I, Abbott RD, Ohshita T, Takahashi T, Ozasa K, Akahoshi M, Fujiwara S, Kodama K, Matsumoto M (2012) A prospective follow-up study of the association of radiation exposure with fatal and non-fatal stroke among atomic bomb survivors in Hiroshima and Nagasaki (1980-2003). BMJ Open 2(1):e000654
15. Walsh L (2012) Neutron relative biological effectiveness for solid cancer incidence in the Japanese A-bomb survivors - an analysis considering the degree of independent effects from γ-ray and neutron absorbed doses with hierarchical partitioning. Radiat Environ Biophys. doi: 10.1007/s00411-012-0445- 6
16. Wang C, Parmigiani G, Dominici F (2012) Bayesian effect estimation accounting for adjustment uncertainty. Biometrics 68:661-686